INOVATYVIOS FARMACIJOS PRAMONĖS ASOCIACIJA - financials and debts
Company age: 28 y. 11 mo.
Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | - | 362,905 | 375,595 | 388,667 | 358,031 |
| Profit before tax | - | - | - | - | 0 | 0 | 0 | 0 |
| Net profit | - | - | - | - | 0 | 0 | 0 | 0 |
| Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | 6,428 | 930 | 820 | 1,700 | 1,581 | 337 | 237 | 909 |
| Non-current assets | 461 | 5 | 5 | 5 | 3,712 | 5,779 | 3,068 | 1,029 |
| Current assets | 307,713 | 357,105 | 304,273 | 462,111 | 506,380 | 515,812 | 505,756 | 543,436 |
| Total assets | 308,174 | 357,110 | 304,278 | 462,116 | 510,092 | 521,591 | 508,824 | 544,465 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 21,941 | 26,393 | 25,758 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | +3.5% | +3.5% | -7.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | 189,338 | 187,798 | 194,334 | 179,016 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-10-25 | 2023-10-30 | 1.94 |
VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
INOVATYVIOS FARMACIJOS PRAMONES ASOCIACIJA (company code 124186557) is an Association operating in activities of business and employers membership organisations. In the latest financial year, 2025, it generated revenue of €358.0K, which was 7.9% lower year on year and 4.7% below the 2023 level. Revenue increased from €375.6K in 2023 to €388.7K in 2024, then declined in 2025, indicating a moderate reversal after one year of growth. Total assets at the end of 2025 stood at €544.5K, up from €508.8K in 2024 and €521.6K in 2023. The asset base was almost entirely short-term, with €543.4K in short-term assets and only €1.0K in long-term assets. Liabilities remained negligible at €909 in 2025. The reported asset turnover ratio was 0.66x, showing that revenue was generated at a moderate pace relative to assets. Revenue per employee was €179.0K, suggesting relatively high output per staff member.